Have a question or want to speak with a team member?
Stay updated on our progress in changing the landscape of ovarian cancer treatment options and outcomes.
Nov 12, 2026
Better outcomes could be more common. Here’s how.
Peggy shares her ovarian cancer story 10 years later and how having the right information can improve outcomes for gynecologic cancers.
Is hormone therapy safe after gynecologic cancer?
Hormone therapy can be safely used by many people with a history of gynecologic cancer, but its safety depends on the type of hormone therapy, cancer type and subtype, and other individual health factors.
Sep 24, 2026
$1 Million for Manitoba-Based Research
Ovarian Cancer Canada is investing in six Manitoba-based research projects thanks to a $1 million commitment from the Province of Manitoba.
Sep 9, 2026
Personalized Cancer Care, Better Quality of Life
Drs. Jamieson and McAlpine are exploring precision treatment to reduce unnecessary side effects for patients with ovarian and endometrial cancer.
Traci: My ovarian cancer story
Ovarian Cancer Awareness Month is deeply personal for me. I was diagnosed with ovarian cancer in 2018, but at the time, cancer was the last thing on my mind.
Exploring survivorship in a three-session Speaker Series
Navigating survivorship. Join us for honest conversations, expert insights and real-world perspectives on life after gynecological cancer treatment.
Aug 13, 2026
What we saw at the Canadian Conference on Ovarian Cancer Research
Before a breakthrough can be uncovered in a research lab, it usually begins with collaboration in a conference room. Here’s what we heard and saw at the Canadian Conference on Ovarian Cancer Research
Jul 16, 2026
News Release: Share Your Voice
After years of advocacy, patients with platinum-resistant ovarian cancer are still waiting for access to a treatment approved by Health Canada and recommended for reimbursement.
May 29, 2026
NEWS RELEASE: Ovarian Cancer Canada and the Cancer Research Society invest in patient-led advances in gynecologic cancer care
Ovarian Cancer Canada and the Cancer Research Society (CRS) are investing $200,000 in two new patient-centered research projects to improve treatment and prevention strategies for Canadians affected by ovarian and endometrial cancers.